SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-288482
Filing Date
2019-11-08
Accepted
2019-11-08 16:57:03
Documents
18
Period of Report
2019-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d811455d8k.htm   iXBRL 8-K 34472
2 EX-1.1 d811455dex11.htm EX-1.1 202293
3 EX-5.1 d811455dex51.htm EX-5.1 9861
4 EX-99.1 d811455dex991.htm EX-99.1 7980
8 GRAPHIC g811455dsp48a.jpg GRAPHIC 13482
9 GRAPHIC g811455dsp5012.jpg GRAPHIC 3339
10 GRAPHIC g811455g1108092301772.jpg GRAPHIC 1649
  Complete submission text file 0001193125-19-288482.txt   459391

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA agio-20191107.xsd EX-101.SCH 3049
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20191107_lab.xml EX-101.LAB 17374
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20191107_pre.xml EX-101.PRE 10939
13 EXTRACTED XBRL INSTANCE DOCUMENT d811455d8k_htm.xml XML 3236
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 191204766
SIC: 2834 Pharmaceutical Preparations